Accelerant Holdings

Accelerant Holdings (ARX) Stock Analysis

$19.730

+0.039 (+0.20%)At close

Loading chart…
High
19.755
Open
19.680
VWAP
19.72
Vol
1.70M
Mkt Cap
Low
19.680
Amount
33.44M
EV/EBITDA, TTM
11.69

Accelerant Holdings is engaged in transforming specialty insurance through advanced data analytics, AI-driven insights, and innovation. It operates a data-driven risk exchange that connects selected specialty insurance underwriters (the Sellers on its platform) with risk capital partners (the Buyers on its platform). Its Risk Exchange reduces information asymmetries and operational barriers present in the traditional insurance value chain by leveraging proprietary technology to share actionable high-fidelity data and insights with platform participants. Its segments include Exchange Services, MGA Operations, and Underwriting. The Exchange Services segment is its core business, its Risk Exchange- the Accelerant technology, data ingestion, and agency operations that serve the needs of its members and risk capital partners. Its technology-powered platform addresses these issues by connecting specialty underwriters, typically managing general agents (MGAs), and risk capital partners.

accelerant.ai

AI analysis of Accelerant Holdings (ARX)

buy

Accelerant Holdings (ARX) is a good buy right now due to its recent surge in stock price to $19.73 following a buyout announcement at $20.25 per share, indicating strong market confidence. The RSI is at an impressive 90.705, suggesting strong momentum. Although the stock has seen volatility, the positive earnings surprise of 100% in the latest report and a projected growth trajectory of 1904.54% from historical patterns support a bullish outlook. The main risk is the recent downgrade by Morgan Stanley, which set a price target of $14, indicating potential downside.

Valuation Metrics

The current forward P/E ratio for Accelerant Holdings (ARX) is 23.70, compared to its 5-year average forward P/E of 23.41.

Forward P/E

Fair
5Y Average P/E
23.41
Current P/E
23.70
Overvalued
29.80
Undervalued
17.02

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
44.34
Current EV/EBITDA
11.69
Overvalued
108.78
Undervalued
-20.10

Forward P/S

Fair
5Y Average P/S
3.04
Current P/S
3.43
Overvalued
4.17
Undervalued
1.90

Whales holding ARX

C

Canoe Financial LP

+ HoldingARX

+5.98%

3M Return

C

Canada Life Investment Management Ltd.

+ HoldingARX

+3.18%

3M Return

Events Timeline

2026-08-13 (ET)

16:30:00

Major Averages Rise as Oil Prices Fall

12:30:00

Accelerant Stock Rises 43.5% to $19.53

12:00:00

Major Averages Rise as Oil Prices Fall

10:30:00

Accelerant Stock Rises 43.5% to $19.52

10:00:00

William Blair Downgrades Accelerant to Market Perform Following Thoma Bravo Deal at $20.25

News

ARX FAQ — answered by Alphio AI

Accelerant Holdings is engaged in transforming specialty insurance through advanced data analytics, AI-driven insights, and innovation. It operates a data-driven risk exchange that connects selected specialty insurance underwriters (the Sellers on its platform) with risk capital partners (the Buyers on its platform). Its Risk Exchange reduces information asymmetries and operational barriers present in the traditional insurance value chain by leveraging proprietary technology to share actionable high-fidelity data and insights with platform participants. Its segments include Exchange Services, MGA Operations, and Underwriting. The Exchange Services segment is its core business, its Risk Exchange- the Accelerant technology, data ingestion, and agency operations that serve the needs of its members and risk capital partners. Its technology-powered platform addresses these issues by connecting specialty underwriters, typically managing general agents (MGAs), and risk capital partners. It operates in the Technology sector.

Accelerant Holdings (ARX) is a good buy right now due to its recent surge in stock price to $19.73 following a buyout announcement at $20.25 per share, indicating strong market confidence. The RSI is at an impressive 90.705, suggesting strong momentum. Although the stock has seen volatility, the positive earnings surprise of 100% in the latest report and a projected growth trajectory of 1904.54% from historical patterns support a bullish outlook. The main risk is the recent downgrade by Morgan Stanley, which set a price target of $14, indicating potential downside.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started